All Indications Are CMS Plans to Launch its 340B Drug Acquisition Survey on Monday

Editor’s note, March 20, 2020: When we published Tweets of Note yesterday, we were unaware of health care economist’s Rena Conti’s March 14 reply to a critic’s tweet the same day. We have added it to this web version of

Read More »

For Now, HRSA Doesn’t Plan to Change Its April 340B Registration Period

For Now, HRSA Doesn’t Plan to Change Its April 340B Registration Period

With health care providers bracing for COVID-19’s full force, the Health Resources and Services Administration (HRSA) at this time does not plan

Read More »

HRSA Tells COVID-19 Responders Concerned About 340B Compliance to Contact it Directly

HRSA Tells COVID-19 Responders Concerned About 340B Compliance to Contact it Directly

The Health Resources and Services Administration (HRSA) is advising health care providers concerned about whether

Read More »

Congressional Medicare Advisers Say 340B Has Minor Effect on Cancer Drug Spending and Patient Cost-Sharing

Congressional Medicare Advisers Say 340B Has Minor Effect on Cancer Drug Spending and Patient Cost-Sharing

Do 340B drug discounts induce hospitals to furnish more-expensive drugs to treat cancer than they otherwise would, raising patients’ coinsurance obligations and the cost of

Read More »

HRSA: 340B Dispute Resolution Will Stay on Hold Until We Get Broader Regulatory Authority

Editor’s note: The Medicare Payment Advisory Commission (MedPAC) is expected to report to Congress tomorrow that 340B’s effects on Medicare Part B beneficiaries’ cost sharing is likely small and varied across patients. We’ll publish an article about the findings and

Read More »

DOJ Says Mallinckrodt Owes Medicaid Hundreds of Millions in Rebates, but Is Silent About 340B Overcharges

DOJ Says Mallinckrodt Owes Medicaid Hundreds of Millions in Rebates, but Is Silent About 340B Overcharges

The U.S. Justice Department is suing drug manufacturer Mallinckrodt for allegedly

Read More »

Distressed Rural Hospitals that Downgrade into Emergency Centers Could Gain 340B Eligibility

Editor’s Note: The 340B Report team is working hard on a special report on key developments from the 340B Coalition Winter Conference Feb. 10-12 in San Diego. We do not plan to publish this Thursday’s edition. Expect to see a detailed

Read More »

Drugmakers Are Doing a Better Job of Supplying 340B Ceiling Price Data, 340B Program Head Pedley Says

Drug manufacturers are doing a better job of providing the Health Resources and Services Administration (HRSA) with timely and accurate data needed to verify their 340B ceiling prices, the head of the federal 340B drug pricing program indicated today. Nonetheless,

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live